June 2, 2017
Japanese generic major Sawai Pharmaceutical said on June 1 that it has completed the acquisition of US generic maker Upsher-Smith Laboratories, which was announced in April. Although the acquisition was put at US$1,050 million (116.5 billion yen), Sawai said that...read more